While the effectiveness of UFSHR on tumor functions is slightly less potent than YM155 in in vitro analysis, this novel survivin inhibitor significantly reduced survivin levels and halted the tumor progression on tumor-bearing mice, when compared to that of the animals treated with vehicle or YM155. This evidence concerns the gene BIRC5 and neoplasm.